nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer
|
VanderWeele, David J. |
|
|
20 |
6 |
p. 575-580 |
artikel |
2 |
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma
|
Talukder, Rafee |
|
|
20 |
6 |
p. 558-567 |
artikel |
3 |
BCG Administration after Prior Radiation Treatment for Prostate Cancer
|
Durant, Adri M. |
|
|
20 |
6 |
p. 591-597 |
artikel |
4 |
Calibrated Regression Models Based on the Risk of Clinical Nodal Metastasis Should be Used as Decision Aids for Prostate Cancer Staging to Reduce Unnecessary Imaging
|
Hayes, Mitchell |
|
|
20 |
6 |
p. e490-e497 |
artikel |
5 |
Clinical and Patient-Reported Outcomes of Advanced Urothelial Carcinoma Following Discontinuation of PD-1/L1 Inhibitor Therapy
|
Morgans, Alicia K |
|
|
20 |
6 |
p. 543-552 |
artikel |
6 |
Clinical Factors Associated With Pathological Grade Group 1 Patients in D'Amico Intermediate-Risk Group Following Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)
|
Sugino, Yusuke |
|
|
20 |
6 |
p. 593-600 |
artikel |
7 |
Clinical Risk Factors Associated With Small Renal Mass Malignant Histology in a Multi-Ethnic Population Undergoing Partial Nephrectomy
|
Zhu, Denzel |
|
|
20 |
6 |
p. e465-e472 |
artikel |
8 |
Complete response in Patients With Lung-Only Metastatic Prostate Cancer: Outcome Analysis
|
Kase, Adam M. |
|
|
20 |
6 |
p. e485-e489 |
artikel |
9 |
Continuous IV Infusion of 5-Flourouracil in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
|
Manogue, Charlotte |
|
|
20 |
6 |
p. 586-590 |
artikel |
10 |
Decreased Muscle Mass Prior to and Following Chemotherapy Predicts Morbidity in Testicular Cancer Patients Undergoing Post-Chemotherapy Retroperitoneal Lymph Node Dissection
|
Baky, FadyJ |
|
|
20 |
6 |
p. e460-e464 |
artikel |
11 |
Editorial Board
|
|
|
|
20 |
6 |
p. A1 |
artikel |
12 |
Evaluation of Provider Preferences in First-Line Metastatic Renal Cell Carcinoma: Comparison Between Dual Immunotherapy vs. Immunotherapy/Tyrosine Kinase Inhibitors
|
Chablani, Priyanka V. |
|
|
20 |
6 |
p. 510-514 |
artikel |
13 |
Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair Comparison
|
Marra, Giancarlo |
|
|
20 |
6 |
p. 592-604 |
artikel |
14 |
Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes
|
Mossanen, Matthew |
|
|
20 |
6 |
p. 568-574 |
artikel |
15 |
Intravesical Therapy Compared to Radical Cystectomy Among Patients With Non-Muscle Invasive Bladder Cancer Requiring Additional Treatment After Induction BCG
|
Anderson, Christopher B. |
|
|
20 |
6 |
p. 595-603 |
artikel |
16 |
Low-Dose Enzalutamide in Metastatic Prostate Cancer—Longevity Over Conventional Survival Analysis
|
Vinh-Hung, Vincent |
|
|
20 |
6 |
p. e473-e484 |
artikel |
17 |
Management and Health Resource Use of Patients With Metastatic Renal Cell Carcinoma treated With Systemic Therapy Over 2014-2017 in France: A National Real-World Study
|
Escudier, Bernard |
|
|
20 |
6 |
p. 533-542 |
artikel |
18 |
Partial Versus Radical Nephrectomy: Complexity of Decision-Making and Utility of AUA Guidelines
|
Campbell, Rebecca A. |
|
|
20 |
6 |
p. 501-509 |
artikel |
19 |
Percutaneous Microwave Ablation is Comparable to Cryoablation for the Treatment of T1a Renal Masses: Results From a Cross-Sectional Study
|
Lucignani, Gianpaolo |
|
|
20 |
6 |
p. e506-e511 |
artikel |
20 |
Risk-Based Assessment Of the Impact Of Intravesical Therapy on Recurrence-Free Survival Rate Following Resection of Suspected Low-grade, Non-muscle-invasive Bladder Cancer (NMIBC): A Southwest Oncology Groups (SWOG) S0337 Posthoc Analysis
|
Corsi, Nicholas J. |
|
|
20 |
6 |
p. e498-e505 |
artikel |
21 |
Table of contents
|
|
|
|
20 |
6 |
p. A3-A7 |
artikel |
22 |
Temporal Characteristics of Adverse Events of Tivozanib and Sorafenib in Previously Treated Kidney Cancer
|
Zengin, Zeynep B. |
|
|
20 |
6 |
p. 553-557 |
artikel |
23 |
The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer
|
Hutten, Ryan |
|
|
20 |
6 |
p. e453-e459 |
artikel |
24 |
The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer
|
Lee, Aaron M. |
|
|
20 |
6 |
p. 515-523 |
artikel |
25 |
Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate Cancer
|
Heath, Elisabeth I. |
|
|
20 |
6 |
p. 524-532 |
artikel |
26 |
Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review of Economic Evaluations
|
Pelloux-Prayer, Rémi |
|
|
20 |
6 |
p. 594-602 |
artikel |
27 |
Two Clinical Cases of Li-Fraumeni Syndrome and Prostate Cancer: Genetic Counseling and Clinical-Surgical Management
|
Abad-Carratalà, Guillem |
|
|
20 |
6 |
p. 581-585 |
artikel |